Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia

Dylan A. Mordaunt, Kim Dalziel, Ilias Goranitis, Zornitza Stark

Research output: Contribution to journalComment/debate

11 Citations (Scopus)
52 Downloads (Pure)

Abstract


Lack of reimbursement for genomic testing in rare diseases is recognized as one of the principal barriers to wider implementation within healthcare systems [1]. Multiple studies have provided evidence for diagnostic and clinical utility and for the cost-effectiveness of genomic testing in rare diseases, leading to testing being funded across a range of public and private healthcare systems worldwide [2].
Original languageEnglish
Pages (from-to)977-979
Number of pages3
JournalEuropean Journal of Human Genetics
Volume31
Issue number9
Early online date3 Jul 2023
DOIs
Publication statusPublished - Sept 2023
Externally publishedYes

Keywords

  • economics
  • health care
  • health care economics
  • health policy

Fingerprint

Dive into the research topics of 'Uptake of funded genomic testing for syndromic and non-syndromic intellectual disability in Australia'. Together they form a unique fingerprint.

Cite this